Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
MAP657Hu21-Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
Recommended Usage
Western blotting: 0.5-2ug/ml Immunocytochemistry in formalin fixed cells: 5-20ug/ml Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml Immunohistochemistry in paraffin section: 5-20ug/ml Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml Optimal working dilutions must be determined by end user.
